CD63 has been suggested as a resistance mediator by tumour-derived exosomes containing doxorubicin and other cytotoxic agents in MCF7 cell lines [33] and mediates anoikis resistance in murine melanoma cell lines [34]. The gene discussed is CD63; the disease is neoplasm.